Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000215610

Medchemexpress LLC 5-(3,3-difluorocyclobutyl)-3-(bicyclo[2.2.2]octan-1-yl)-1,2,4-oxadiazole | 935273-79-3 | MFCD30343842 | 99.2% | 493.47 g/mol | C24H24F5N5O | 100 MG
SDP

Supplier:  Medchemexpress LLC HY100036100MG

Encompass_Preferred

MK-4101 is a small-molecule Smoothened (SMO) antagonist and hedgehog pathway inhibitor used for research applications, including in vitro pathway studies and preclinical cancer research. It shows antitumor activity by inhibiting tumor cell proliferation and inducing apoptosis.

  • Small-molecule SMO antagonist suitable for in vitro and preclinical studies.
  • High reported purity of 99.16%.
  • Molecular weight 493.47 g/mol and formula C24H24F5N5O.
  • Soluble in DMSO at ≥50 mg/mL; in vivo formulation protocols available.
  • Recommended storage: powder -20°C (3 years) or 4°C (2 years); in solvent -80°C (2 years).
  • Reported cellular potency in the low micromolar range (IC50 values).

Catalog No. 50-002-15610


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.